Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Faquin

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Cancer Cytopathology|February 2, 2023
Generalists and specialists: Two sides of the same coin for cancer care?: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tapBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2026
A growing brain drain: US policies are spurring medical researchers to pursue other options: In this third of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists are increasingly looking abroad for better offers and more stabilityBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2026
Cysteine-mapping efforts offer new tools for drug development and discovery: Research groups are characterizing cysteine binding and reactivity traits to provide important new starting points for drug designBryn Nelson, William Faquin
Cancer Cytopathology|January 2, 2023
Cancer-linked genetic testing: The key role of cultural influences: In this second of a two-part series, genetic testing for hereditary cancers is promising more targeted approaches to prevention and intervention, but cultural differences in perceptions of utility, autonomy, and decision-making loom large in determining whether and how such testing is conducted: In this second of a two-part series, genetic testing for hereditary cancers is promising more targeted approaches to prevention and intervention, but cultural differences in perceptions of utility, autonomy, and decision-making loom large in determining whether and how such testing is conductedBryn Nelson, William Faquin
Cancer Cytopathology|June 3, 2024
Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeedBryn Nelson, William Faquin
Cancer Cytopathology|January 5, 2026
Coming apart: How US travel and immigration policies are fraying the future of cancer research: In this first of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists warn of a chilling effect on recruiting and retaining international talentBryn Nelson, William Faquin
Cancer Cytopathology|September 4, 2025
New urgency for answers on the health impacts of microplastics: In this first of a two-part series on early studies of microplastics and nanoplastics, researchers are finding numerous hints of health effects-and warnings of a far greater potential for harmBryn Nelson, William Faquin
Cancer Cytopathology|January 20, 2025
Amid a boom in organ donation, a heightened focus on cancer risk in transplant recipients: Immunosuppression, transmissible infections and tumors, and improved long-term survival among organ recipients are requiring more vigilance for skin cancers and other malignanciesBryn Nelson, William Faquin
Cancer Cytopathology|November 3, 2025
The heavy health costs of a chemical "that's too big to fail": Despite longstanding ties linking formaldehyde to cancer and other diseases, lessening the danger of the ubiquitous chemical remains a hard liftBryn Nelson, William Faquin
Cancer Cytopathology|September 5, 2023
New chances and challenges for preventing HPV associated throat cancer: Otolaryngologists sense an opening for increasing vaccination rates and decreasing the incidence of HPV-associated oropharyngeal cancerBryn Nelson, William Faquin
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Cancer Cytopathology|February 2, 2023
Generalists and specialists: Two sides of the same coin for cancer care?: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tapBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2026
A growing brain drain: US policies are spurring medical researchers to pursue other options: In this third of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists are increasingly looking abroad for better offers and more stabilityBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2026
Cysteine-mapping efforts offer new tools for drug development and discovery: Research groups are characterizing cysteine binding and reactivity traits to provide important new starting points for drug designBryn Nelson, William Faquin
Cancer Cytopathology|January 2, 2023
Cancer-linked genetic testing: The key role of cultural influences: In this second of a two-part series, genetic testing for hereditary cancers is promising more targeted approaches to prevention and intervention, but cultural differences in perceptions of utility, autonomy, and decision-making loom large in determining whether and how such testing is conducted: In this second of a two-part series, genetic testing for hereditary cancers is promising more targeted approaches to prevention and intervention, but cultural differences in perceptions of utility, autonomy, and decision-making loom large in determining whether and how such testing is conductedBryn Nelson, William Faquin
Cancer Cytopathology|June 3, 2024
Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeedBryn Nelson, William Faquin
Cancer Cytopathology|January 5, 2026
Coming apart: How US travel and immigration policies are fraying the future of cancer research: In this first of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists warn of a chilling effect on recruiting and retaining international talentBryn Nelson, William Faquin
Cancer Cytopathology|September 4, 2025
New urgency for answers on the health impacts of microplastics: In this first of a two-part series on early studies of microplastics and nanoplastics, researchers are finding numerous hints of health effects-and warnings of a far greater potential for harmBryn Nelson, William Faquin
Cancer Cytopathology|January 20, 2025
Amid a boom in organ donation, a heightened focus on cancer risk in transplant recipients: Immunosuppression, transmissible infections and tumors, and improved long-term survival among organ recipients are requiring more vigilance for skin cancers and other malignanciesBryn Nelson, William Faquin
Cancer Cytopathology|November 3, 2025
The heavy health costs of a chemical "that's too big to fail": Despite longstanding ties linking formaldehyde to cancer and other diseases, lessening the danger of the ubiquitous chemical remains a hard liftBryn Nelson, William Faquin
Cancer Cytopathology|September 5, 2023
New chances and challenges for preventing HPV associated throat cancer: Otolaryngologists sense an opening for increasing vaccination rates and decreasing the incidence of HPV-associated oropharyngeal cancerBryn Nelson, William Faquin
Pageof 10